Aims/hypothesis This research aimed to define the pathophysiological defects responsible for the elevated fasting plasma glucose (FPG) concentration and excessive rise in post-load plasma glucose observed in individuals with impaired fasting glucose (IFG). Methods We used tracer techniques to quantify basal splanchnic (primarily hepatic) glucose uptake and glucose fluxes following glucose ingestion in individuals with normal glucose tolerance (NGT; n = 10) and IFG (n = 10). Results Individuals with IFG had a comparable basal rate of hepatic glucose production to those with NGT (15.2 ± 0.2 vs 18.0 ± 0.8 μmol min −1 [kg lean body mass (LBM)] −1 ; p = 0.09). However, they had a significantly reduced glucose clearance rate during the fasting state compared with NGT (2.64 ± 0.11 vs 3.62 ± 0.20 ml min ; p = 0.02). Following glucose ingestion, the total amount of exogenous glucose that appeared in the systemic circulation was not significantly different between groups. However, suppression of endogenous glucose production (EGP) was markedly impaired in individuals with IFG. Conclusions/interpretation These results demonstrate that decreased tissue (liver) glucose uptake, not enhanced EGP, is the cause for elevated FPG concentration in individuals with IFG, while the excessive rise in plasma glucose concentration following a glucose load in these individuals is the result of impaired suppression of hepatic glucose production.
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normal glucose tolerance (NGT) and overt type 2 diabetes mellitus [1] . This category of disease was meant to identify individuals at increased future risk of type 2 diabetes mellitus without the need for an OGTT. Compared with those with NGT, individuals with IFG, such as those with impaired glucose tolerance (IGT), manifest a fivefold greater risk of progression to type 2 diabetes [2] . Many previous studies [3] [4] [5] [6] [7] [8] [9] have documented distinct metabolic abnormalities in IFG and IGT. Individuals with IGT manifest severe insulin resistance in skeletal muscle and impaired second phase insulin secretion, while those with IFG manifest normal/near normal insulin sensitivity in skeletal muscle and impaired first phase insulin secretion [3] [4] [5] [6] [7] [8] [9] . Because insulin-mediated muscle glucose uptake is the principal factor responsible for the disposal of a glucose load, the combination of severe muscle insulin resistance and impaired second phase insulin secretion explains the elevated 2 h plasma glucose concentration observed in IGT individuals [3, 4] . Conversely, the normal/near normal insulin sensitivity in skeletal muscle and normal second phase insulin secretion in individuals with IFG explains why the 2 h plasma glucose concentration returns to starting fasting, albeit elevated, levels in these patients [3, 4] . Despite the return of 2 h plasma glucose concentration to the starting fasting level in patients with IFG, there is an excessive rise in the plasma glucose concentration after a glucose load, e.g. at 60 and 75 min during an OGTT and mixed meal tests [3] . We previously demonstrated that the 1 h plasma glucose concentration during an OGTT is the strongest predictor of future type 2 diabetes risk, independent of glucose tolerance status [10, 11] , and that individuals with IFG with a 1 h plasma glucose >8.6 mmol/l manifest a fourfold greater risk of future type 2 diabetes than those with IFG and 1 h plasma glucose levels <8.6 mmol/l [10, 12] . Thus, it is important to identify the metabolic abnormality responsible for the excessive post-load rise in plasma glucose concentration in individuals with IFG. Although the double-tracer technique is widely used to assess the contribution of exogenous glucose absorption vs endogenous glucose production (EGP) to the elevation in plasma glucose concentration following glucose ingestion in type 2 diabetes patients [13] [14] [15] [16] , no previous study has used this technique to examine the source of the excessive rise in plasma glucose concentration following glucose ingestion in individuals with IFG.
Despite a wealth of previous studies [3] [4] [5] [6] [7] [8] [9] [17] [18] [19] [20] [21] [22] that have examined the pathophysiology of IFG and identified multiple metabolic defects, including hepatic insulin resistance and impaired first phase insulin secretion, none of these defects explain the elevated FPG concentration in individuals with IFG. The basal rate of EGP (bEGP) is the principal determinant of FPG concentration [23] . We [4] and others [6] [7] [8] have previously demonstrated that individuals with IFG manifest moderate to severe hepatic insulin resistance. However, elevated fasting plasma insulin concentration offsets hepatic insulin resistance and maintains the bEGP in the normal range [24] . Indeed the vast majority [4-9, 17, 18] , though not all [19, 22] , previous studies have failed to document a significant rise in bEGP in individuals with IFG compared with NGT. Of note, some investigators who reported an elevated bEGP in IFG in some studies [19, 22] also reported a normal bEGP in others [6, 9, 18] . Moreover, even in individuals with type 2 diabetes, the increase in bEGP becomes evident only when FPG concentration exceeds ∼8.9 mmol/l [23, 24] . A normal bEGP in individuals with IFG in the presence of an elevated FPG concentration suggests decreased glucose clearance rate. Consistent with this hypothesis, we have previously demonstrated that participants with IFG manifest a decreased basal rate of glucose clearance during the fasting state [25] .
Under fasting conditions, the majority of basal glucose uptake (∼11.1 μmol kg −1 min −1 ) takes place in insulinindependent tissues. Approximately one half of basal glucose uptake (∼5.55 μmol kg −1 min −1 ) occurs in the brain [26] , while the other half is taken up in an insulin-independent manner, approximately equally by the skeletal muscle and liver [26] . Analytical determinations Plasma glucose concentration was determined by the glucose oxidase method (Analox Glucose Analyzer; Analox Instruments, Lunenburg, MA, USA). Plasma insulin and glucagon concentrations were determined by radioimmunoassay (Diagnostic Products, Los Angeles, CA, USA). Plasma H]glucose and [1-14 C]glucose radioactivity levels were determined by the Somogyi procedure, as previously described [4, 13] . Briefly, a plasma sample was deproteinised with barium hydroxide and zinc sulphate. The deproteinised supernatant fraction was then evaporated to dryness to remove 3 H 2 O, reconstituted with water, and radioactivity was counted.
Calculations and statistical analysis During the doubletracer OGTT test, the bEGP was calculated as H]glucose infusion rate (dpm/min) divided by the steady-state plasma H]glucose specific activity (dpm/μmol). After glucose ingestion, non-steady-state conditions for plasma glucose concentration prevail, during which the total rate of appearance (R a ) of glucose in the systemic circulation (R a T) was computed from the change in plasma [3-3H] glucose specific activity using Steele's equation, as previously reported [4, 13] . The [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] C]glucose data were used to calculate the R a of oral glucose (R a O). After glucose ingestion, residual rate of EG-P (rEGP) was calculated as the difference between R a T and R a O [13] .
During the oral-i.v. double-tracer infusion study, the bEGP was calculated for [3-tivity (dpm/μmol). Only the [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] C]glucose that escapes the liver and non-hepatic splanchnic tissues appears in the systemic circulation, while all infused H]glucose appears in the systemic circulation. Therefore, the difference between R a of [3- . Data are presented as mean ± SEM. Differences between means were tested with Student's t test; statistical significance was set at p < 0.05.
Results
Participant characteristics As per study design, individuals with IFG had a significantly higher FPG concentration than individuals with NGT (5.83 ± 0.11 vs 4.94 ± 0.11 mmol/l, respectively; p < 0.0001). NGT and IFG groups were well matched for age (31 ± 4 vs 38 ± 5 years, respectively; p = 0.48) and sex (female/male: 6/4 in NGT vs 4/6 in IFG). BMI did not significantly differ between the two groups (NGT: 30.7 ± 1.1 kg/m 2 ; IFG: 28.6 ± 2.1 kg/m 2 ; p = 0.18). Body fat per cent was similar in the two groups (NGT: 0.328 ± 0.05; IFG: 0.321 ± 0.04). Importantly, the 2 h plasma glucose concentration during the OGTT was similar in IFG and NGT individuals (6.28 ± 0.28 vs 5.94 ± 0.18 mmol/l, respectively, p = 0.38).
Fasting splanchnic glucose uptake During the oral-i.v. double-tracer infusion study, the bEGP (primarily reflecting hepatic glucose production) was measured using [3- ; p < 0.01). For each participant in each group, the basal rate of glucose appearance was lower when measured using [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] C]glucose than when measured using H]glucose (Fig. 1a) ; p = 0.02; Fig. 1b) . Further, the basal rate of splanchnic glucose uptake strongly and inversely correlated with the FPG concentration (r = −0.72, p < 0.001; Fig. 1c ).
Glucose kinetics following oral glucose load In individuals with IFG, the plasma glucose concentration between 45 and 105 min following glucose ingestion increased to significantly higher values than in individuals with NGT (Fig. 2a) . The peak plasma glucose concentration was reached at 45 min in both groups and was 1.3 mmol/l higher in individuals with IFG vs NGT (10.3 ± 0.5 vs 9.0 ± 0.4 mmol/l; p < 0.05). However, the 2 h plasma glucose concentration was comparable in both groups (7.5 ± 0.2 vs 7.2 ± 0.3 mmol/l; p = 0.42), as was the plasma glucose concentration between 2 and 4 h during the OGTT. Plasma insulin concentration between 45 and 120 min was also significantly greater in IFG vs NGT individuals (Fig. 2b) . On the other hand, fasting plasma glucagon concentration did not significantly differ between the two groups (IFG vs NGT: 47 ± 3 vs 60 ± 4 ng/l; p = 0.31) and the decrement in plasma glucagon concentration during the OGTT was comparable in both groups (Fig. 2c) . Thus, the fasting insulin:glucagon ratio was significantly higher in IFG vs NGT individuals (0.14 ± 0.03 vs 0.05 ± 0.01; p < 0.05), and this ratio increased to 2.26 ± 0.38 vs 1.10 ± 0.18, between 0 and 120 min (p = 0.006;).
Since the plasma glucose concentration was comparable in both IFG and NGT groups after 120 min during the OGTT (Fig. 2a) , we calculated the amount of glucose that appeared in the systemic circulation during the initial 0-120 min of the OGTT. From 0-120 min after glucose ingestion, R a T was significantly greater in individuals with IFG vs NGT (0.29 ± 0.02 vs 0.24 ± 0.01 mol; p = 0.01; Table 1 ). Despite the greater R a T in individuals with IFG, R a O between 0 and 120 min was not significantly different between groups (NGT vs IFG: 0.22 ± 0.01 vs 0.20 ± 0.02 mol; p = 0.73; Table 1 ). Thus, the portion of the ambient plasma glucose concentration originating from ingested glucose was similar in IFG and NGT groups (Fig. 3a) . Conversely, at 45-120 min of the double-tracer OGTT, the suppression of bEGP in individuals with IFG was significantly impaired compared with those with NGT (Fig. 3b) . Furthermore, the amount of glucose produced by the liver (rEGP) between 0 and 120 min was significantly greater in individuals with IFG vs NGT (0.06 ± 0.02 vs 0.02 ± 0.01 mol, p = 0.008, Table 1 ). Also, rEGP between 0 and 120 min significantly and inversely correlated with the basal rate of splanchnic glucose uptake (r = −0.41, p < 0.05). Thus, the portion of ambient plasma glucose concentration originating from the liver after glucose ingestion was significantly higher in IFG vs NGT individuals (Fig. 3c) .
Mean fasting plasma NEFA concentration was similar in both groups (IFG vs NGT: 0.49 ± 0.05 vs 0.46 ± 0.04 mmol/l, p = 0.78). Because individuals with IFG had significantly greater increases in fasting plasma insulin concentration during the OGTT than those with NGT (Fig. 2b) , the adipocyte insulin resistance index (the product of fasting plasma insulin concentration and fasting plasma NEFA concentration) was significantly greater in individuals with IFG (data not shown). Despite higher plasma insulin concentration during the OGTT in participants with IFG, the suppression of plasma NEFA concentration after glucose ingestion was significantly greater in individuals with NGT at 30 and 60 min (Fig. 4) .
Discussion
The results of the present study provide two major novel observations that help to elucidate the disturbances in basal and post-load glucose fluxes responsible for fasting and postprandial hyperglycaemia, respectively, in individuals with IFG. The splanchnic glucose balance in individuals with IFG in the presence of an elevated FPG concentration, fasting hyperinsulinaemia and lower fasting plasma glucagon concentration, indicates impaired suppression of hepatic glucose production by the combined effects of glucose and insulin, i.e. hepatic insulin resistance. The decreased basal rate of splanchnic glucose uptake observed in participants with IFG is consistent with the decreased basal glucose clearance previously reported by our lab [25] and suggests that the elevated FPG concentration in these individuals is not due to increased glucose production by the liver during sleep, but rather is the result of decreased splanchnic (primarily hepatic) glucose uptake during sleeping hours in the presence of a 'normal' rate of EGP. Of note, splanchnic glucose uptake is insulin independent and is primarily determined by hepatic glucokinase activity. Consistent with this, a recent study [28] demonstrated decreased hepatic glucokinase activity in individuals with IFG. The second major novel finding in the present study is that the excessive rise in plasma glucose concentration in individuals with IFG following glucose ingestion is not due to an increased rate of glucose absorption (Fig. 3a) but is rather a result of impaired suppression of EGP (Fig. 3b) . Participants with IFG had a significantly greater rise in plasma glucose concentration during the initial 45-120 min of the OGTT, compared with the NGT group (Fig. 2a) . This rise in plasma glucose concentration has resulted from an increased R a T (Table 1) . Between 0 and 120 min following glucose ingestion, more glucose (8 g) appeared in the systemic circulation in individuals with IFG than in NGT. This excess glucose appearance likely has contributed to the excessive rise in plasma glucose concentration.
The present study also identified the source of the excess glucose appearance in individuals with IFG. No significant difference was observed in the rate of ingested glucose appearance (R a O) in the systemic circulation in the IFG vs NGT group (Table 1) . The portion of the ambient plasma glucose concentration originating from ingested glucose was similar in IFG and NGT groups (Fig. 3a) . Conversely, the suppression of EGP between 0 and 120 min following glucose ingestion was impaired in individuals with IFG vs NGT and resulted in the 'addition' of an excess ∼56 mmol of glucose in the circulation (Table 1) . Thus, impaired suppression of EGP was the primary cause of postprandial hyperglycaemia in individuals with IFG. Of note, the impaired suppression of EGP in IFG was present despite significantly higher plasma insulin (Fig. 2b) and significantly higher plasma insulin:glucagon ratio, emphasising the severity of hepatic insulin resistance in individuals with IFG. We [4, 25] and others [5] [6] [7] [8] 28] have previously shown that the ability of insulin to suppress EGP is impaired in individuals with IFG. The impaired suppression of EGP following glucose ingestion in participants with IFG in the present study is consistent with these findings and extends them by demonstrating that this impairment in EGP suppression leads to the excessive rise in plasma glucose concentration observed in these individuals following glucose ingestion.
Although individuals with IFG and NGT had comparable fasting plasma NEFA concentration, those with IFG manifest insulin resistance in adipocytes. This was evident by the significantly elevated adipocyte insulin resistance index observed in the participants with IFG, both during the fasting state and after glucose ingestion (data not shown), and in the impaired suppression of plasma NEFA concentrations at 30 and 60 min during the OGTT (Fig. 4) . Because in general, individuals spend most of the day in the fed state, it is possible that impaired NEFA suppression in IFG subjects results in a greater supply of NEFA to the liver, which may had contributed to the impairment in hepatic glucose metabolism (impaired HGU and suppression of EGP). Although HGU is insulin independent, the inverse relationship between rEGP and HGU (data not shown) may suggest a common mechanism underlying these hepatic defects.
One limitation of the present study is that the oral-i.v. double-tracer infusion technique measures the basal rate of splanchnic glucose uptake and cannot distinguish between hepatic and non-hepatic splanchnic tissues. However, because the majority of splanchnic glucose uptake (>90%) is by the liver [26] , it is likely that the decreased basal glucose clearance in IFG is accounted for by a decrease in HGU. Because of the intensive nature of the procedures used in the present study, a relatively small number of individuals were included in the study. Another limitation of the study is that by chance all individuals with IFG had FPG concentration between 5.6 and 6.1 mmol/l. However, the difference in mean FPG concentration between IFG and NGT groups was relatively large (∼1 mmol/l). A strength of our study comes about from the rate of basal glucose production being expressed per kg LBM; because of this a difference in body fat per cent between different individuals is unlikely to have contributed to the decreased basal splanchnic glucose uptake in individuals with IFG compared to those with NGT. Prior studies [29] have demonstrated that when normalised to LBM, hepatic glucose production is similar in obese and lean individuals over a wide BMI range.
In summary, the results of the present study demonstrate that reduced splanchnic glucose uptake during the fasting state causes elevated FPG concentration in individuals with IFG. They also show that the excessive rise in the plasma glucose concentration following a glucose load in IFG is due to impaired suppression of EGP. These findings underscore the importance of hepatic glucose metabolism in the pathogenesis of IFG.
